Specialty Pharmacy

Purchasing and distributing supplies traditionally accounts for less than half of a health system's operating costs. Over time, that proportion has increased, necessitating optimization of product distribution systems.

Many patients do not fully understand the risks of unnecessary antibiotic prescribing.

Combinations of drugs already approved found to be safe in treatment of rare disease.

Vaccine therapy stimulates immune defenses.

Tips and statistics surrounding the challenge of medication adherence.

Study suggests drug has negative impact on immune system.

Pharmacists charged with distributing tainted drugs that caused a fungal meningitis outbreak that killed 64 individuals.

A new study has revealed that many patients infected with the hepatitis C virus do not seek treatment and become lost in the different stages of health care to manage the disease.

Multi-year agreement with AbbVie will place new drug as the exclusive option for patients with hepatitis C genotype 1.

Study finds doctors shift health care services to Medicare when they can profit from doing so.

A bill to make pharmacy benefit managers' reimbursements for generic drugs more transparent will cover more federal health care programs than a bill introduced earlier this year.

Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses developing trends in copay and reimbursement assistance that specialty pharmacies need to be aware of.

One important reason for maintenance of Saturday delivery by the United States Postal Service was the importance of weekend delivery in the supply of medications through mail-order pharmacies.

Olaparib (Lynparza) was approved with companion diagnostic that detects mutations in BRCA genes.

Nivolumab treats patients with unresectable or metastatic melanoma who no longer respond to other drugs.

Data for daclatasvir not suitable to prove added benefit.

Related study shows satisfied specialty pharmacy members more likely to be adherent to their biologic anti-inflammatory medicines.

Lanreotide is first antitumor drug to show statistically significant progression-free survival in patients with gastrointestinal and pancreatic tumors.

The FDA today approved ombitasvir, paritaprevir, and ritonavir tablets copackaged with dasabuvir tablets to treat individuals with chronic hepatitis C virus genotype 1 infection, including patients with cirrhosis.

Olaparib treats women with advanced ovarian cancer associated with defective BRCA genes.

Pharmacists tied medical doctors for second place in Gallup's latest honesty and ethics poll.

Study finds hepatitis C co-infection not related to decreased mental function.

FL118 could be effective in treating late stage cancers.

Avella Specialty Pharmacy announced today that Dr. Eric Sredzinski, Pharm.D. is among a team of researchers that received the 2014 Pharmacy Practice Research Award from the American Society of Health-Systems Pharmacists Research and Education Foundation.

To curb an estimated 6% to 11% increase in Medicare Part D spending, 3 states have already placed limitations on which patients with chronic hepatitis C are candidates for treatment with novel antiviral agents.

Thomas Morrow, MD, chief medical officer at Next IT, discusses hurdles that specialty pharmacies need to overcome.

Acro Pharmaceutical Services annual symposium brings together key players from through the specialty pharmacy landscape.

Specific type of non-steroidal anti-inflammatory drugs can increase heart attack risk for some people.